DelveInsight’s Diabetic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Diabetic Kidney Disease (DKD) , historical and forecasted epidemiology as well as the Diabetic Kidney Disease (DKD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Diabetic Kidney Disease Overview
Diabetic Kidney Disease is a type of kidney disease caused by diabetes, when high blood glucose initiate to damage the blood vessels in kidneys and creates problem in its functioning. Kidney damage caused by diabetes usually occurs slowly, over many years. Diabetic kidney disease is also called as chronic kidney disease, CKD, kidney disease of diabetes, or diabetic nephropathy.
Request free sample copy- https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market
Regions Covered in the report
List of companies involved in the report
Diabetic Kidney Disease Symptoms
The basic symptoms of DKD are swelling of the hands, feet, and face, trouble sleeping or concentrating, poor appetite, nausea, weakness, itching (end-stage kidney disease) and extremely dry skin, drowsiness (end-stage kidney disease), abnormalities in the hearts’ regular rhythm because of increased potassium in the blood, muscle twitching etc.
Diabetic Kidney Disease Market Report
DKD generally results due to high blood glucose, smoking, high salt intake in regular diet, overweight, history of heart disease, family history of kidney failure that can damage the blood vessels in the kidneys, which thereby results into high blood pressure that can damage the kidneys further. The early symptoms are worsening blood pressure control, protein in the urine, swelling of feet, ankles, hands or eyes.
Diabetic Kidney Disease Treatment Market
Currently, the treatment paradigm for DKD includes few treatment options such as lowering blood pressure, maintaining blood sugar, dialysis and renal transplant. The market of DKD holds few US FDA approved drugs, such as, Invokana (Canagliflozin) which is marketed by Janssen Pharmaceuticals and Capoten (captopril) marketed by Bristol-Myers Squibb. Capoten was approved by FDA for Diabetic Nephropathy, which works by inhibition of ACE resulting in decreased plasma angiotensin II and increased plasma renin activity (PRA).
Diabetic Kidney Disease Market Insights
The initial method to cure DKD is lowering blood pressure as a mild rise in blood pressure can quickly make kidney disease worsen. Additionally, maintaining blood sugar is absolutely necessary to slow the progression of diabetic nephropathy. The basic ways to lower blood pressure are losing weight, eating less salt, avoiding alcohol and tobacco, and getting regular exercise.
Diabetic Kidney Disease Market Report Scope
Table of content
1. Key Insights
2. Executive Summary of Diabetic Kidney Disease (DKD)
3. Competitive Intelligence Analysis for Diabetic Kidney Disease (DKD)
4. Diabetic Kidney Disease (DKD): Market Overview at a Glance
5. Diabetic Kidney Disease (DKD): Disease Background and Overview
6. Patient Journey
7. Diabetic Kidney Disease (DKD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Diabetic Kidney Disease (DKD) Treatment
11. Marketed Products
12. Emerging Therapies
13. Diabetic Kidney Disease (DKD): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Diabetic Kidney Disease (DKD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/